Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
FTC
Indivior Agrees to FTC Settlement Over Suboxone Claims
Recently, Indivior, Inc. agreed to pay $10 million to settle allegations by Federal Trade Commission (FTC) that it violated…
FDA and FTC Taking Quick Action Against COVID Scammers
Since the declaration of a public health emergency related to COVID-19 in February 2020, there has been an overwhelming response…
FDA and FTC Join Forces on Biosimilar Marketing
Earlier this month, the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) released a joint statement about…
What Constitutes Pay-for-Delay?
In January, oral arguments in the 3rd Circuit Court of Appeals case between the Federal Trade Commission (FTC) and AbbVie delved…
FTC Report Finds Fewer Anticompetitive Reverse Payment Deals in…
The Federal Trade Commission’s (“FTC”) Bureau of Competition published a report that found that, despite an increase in the total…
Mallinckrodt Settles Anti-Competitive Practices Suit
Mallinckrodt and the Federal Trade Commission (FTC) recently agreed to settle allegations of raising drug prices and engaging in…
Citizen Petitions to Come Front and Center
In February, the Federal Trade Commission filed a complaint in federal district court charging Shire ViroPharma Inc. with…
Mallinckrodt to Pay $100M to Settle Antitrust Violations
Mallinckrodt ARD Inc., formerly known as Questcor Pharmaceuticals, Inc., and its parent company, Mallinckrodt plc, have agreed to…
Senator Klobuchar Calls on FTC To Investigate Pharma Companies for…
Last week, U.S. Senator Amy Klobuchar (D-MN) called on the Federal Trade Commission (FTC) to investigate pharmaceutical…
FTC Urges FDA To Reevaluate Current Approach To Regulating Homeopathic…
Last week, the Federal Trade Commission (FTC) recommended that the Food and Drug Administration (FDA) consider…